^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
FirstSight™ CRC Test

Company:
CellMax Life
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
FirstSight™ CRC Test detects and analyzes circulating tumor cells (CTCs) and is intended to predict the likelihood of having precancerous adenomatous polyps or colorectal cancer (CRC) in patients eligible for CRC screening. The FirstSight assay evaluates 3 biomarkers: circulating gastrointestinal epithelial cells, validated somatic oncogene and tumor suppressor mutations, and methylation with Septin9 of cell-free tumor DNA (cfDNA).
Cancer:
Colorectal Cancer
Method:
Liquid biopsy